# FDA recall D-0098-2018

> **Mayne Pharma Inc** · Class II · drug recall initiated 2017-11-09.

## Product

Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles,  Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01

## Reason for recall

Failed Dissolution Specifications.

## Distribution

Nationwide within USA

## Key facts

- **Recall number:** D-0098-2018
- **Recalling firm:** Mayne Pharma Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-11-09
- **Report date:** 2017-12-06
- **Termination date:** 2020-05-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Greenville, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0098-2018

## Citation

> AI Analytics. FDA recall D-0098-2018. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-0098-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*